Let's talk medical research

MS is a chronic disease that is estimated to impact over a million Americans. The condition causes damage to the body’s central nervous system, leading to numbness, memory problems, sight issues, and difficulties with coordination.

We’re thrilled to announce a collaboration with our partners at Melanoma Research Alliance to bring a curated experience to patients and caregivers impacted by melanoma. In the United States, melanoma is one of the most common types of cancer, and its prevalence has tripled in recent decades. It is estimated that 100,000 people will be diagnosed with invasive melanoma each year, and more than 1.4 ...

We’re thrilled to announce a collaboration with our partners at Melanoma Research Alliance to bring a curated experience to patients and caregivers impacted by melanoma. In the United States, melanoma is one of the most common types of cancer, and its prevalence has tripled in recent decades. It is estimated that 100,000 people will be diagnosed with invasive melanoma each year, and more than 1.4 ...

Though it normally begins with mild memory loss, Alzheimer’s disease is a progressive condition that will eventually develop into a severely life-altering affliction. Alzheimer’s disease is the most common type of dementia, estimated to impact more than 6 million Americans, most of whom are over the age of 65.

Receiving a multiple sclerosis (MS) diagnosis can feel overwhelming and isolating for many. MS is a neurodegenerative disease that often involves challenging symptoms — but knowing what to expect and what resources are available can help.

For many people, participating in a research study presents an interesting opportunity with many benefits to volunteering. While there are many types of clinical research, all with distinct goals and timelines, trial volunteers will follow a similar path when taking part. Read on to learn more about the process.

When conducting medical research, recruiting patients can be one of the most difficult processes. Reaching the right patients and engaging them with a study poses a pervasive challenge. Fortunately, there are strategies to overcome these difficulties and keep a study’s timeline on track.

Rare Disease Day, typically observed on February 28th, will be celebrated this year on February 29th! Rare Disease Day is an awareness holiday intended to generate change for the 300 million people who are diagnosed with a rare disease worldwide, as well as their families and caregivers.

Electronic patient-reported outcomes (often abbreviated to ePRO) are tools intended to collect patient data in clinical trials through methods such as diaries, phone apps, tablets, and other devices. These tools are useful for streamlining the work required by site staff and also create a more patient-centric environment in clinical trials.

We’re here with Antidote’s tenth installment of Talk of the Towne, and it’s a very special one! We recently attended SCOPE 2024, where we met up with our partners at Rare Patient Voice and recorded our first Talk of the Towne episode live and in person.